Expression and Clinical Significance of CD30 and CD56 in Lymphoblastic Lymphoma: A Retrospective Analysis on Paraffin-Embedded Tissues by Immunohistochemistry-Reference-Cited by-同舟云学术

Expression and Clinical Significance of CD30 and CD56 in Lymphoblastic Lymphoma: A Retrospective Analysis on Paraffin-Embedded Tissues by Immunohistochemistry

Published:2024-01-11 Issue:2 Volume:43 Page:111-122
ISSN:1551-3815
Container-title:Fetal and Pediatric Pathology
language:en
Short-container-title:Fetal and Pediatric Pathology

Author:

Li Shuqi¹,Zheng Shuang¹²,Huang Xinyi¹,Zhang Wenhui¹,Liu Fang³⁴,Cao Qinghua¹

Affiliation:

1. Department of Pathology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China

2. Department of Pathology, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, China

3. State Key Laboratory of Organ Failure Research, Guangdong Provincial Key Laboratory of Viral Hepatitis Research, Department of Infectious Diseases, Department of Liver Tumor Center, Nanfang Hospital, Southern Medical University, Guangzhou, China

4. Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China

Funder

National Natural Science Foundation of China

Natural Science Foundation of Guangdong Province

President Foundation of Nanfang Hospital, Southern Medical University

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/15513815.2023.2301459

Reference23 articles.

1. Lymphoblastic lymphoma

2. T cell lymphoblastic lymphoma with uncommon CD20 expression

3. CAR T-cell therapy for a relapsed/refractory acute B-cell lymphoblastic lymphoma patient in the context of Li-Fraumeni syndrome

4. Advances in CD30- and PD-1-targeted therapies for classical Hodgkin lymphoma

5. Brentuximab vedotin therapy for CD30-positive cutaneous T-cell lymphoma: a targeted approach to management